Table 3. Laboratory results of patients under investigation with and without COVID-19.
| Variable, median (IQR) | COVID-19 (n = 6) | Non-COVID-19 (n = 23) | P-value |
|---|---|---|---|
| White blood cells, cells/mm3 | 6,100 (4,500–6,800) | 9,600 (7,500–12,900) | 0.002 |
| Neutrophil, % | 62 (43–74) | 76 (68–87) | 0.101 |
| Lymphocyte, % | 26 (20–44) | 14 (6–23) | 0.056 |
| Monocyte, % | 11 (9–11) | 7 (4–8) | 0.030 |
| Hemoglobin, g/dL | 13 (13–13) | 11.5 (11–14) | 0.372 |
| Platelet, cells/mm3 | 236,000 (180,000–274,000) | 260,000 (177,000–306,000) | 0.484 |
| Blood urea nitrogen, mg/dL | 7 (7–9) | 12 (9–16) | 0.172 |
| Creatinine, mg/dL | 1 (1–1) | 1 (1–1) | 0.089 |
| Aspartate aminotransferase, U/L | 44 (42–50) | 33 (22–60) | 0.650 |
| Alanine aminotransferase, U/L | 23 (23–26) | 28.5 (20–82) | 0.626 |
| Total bilirubin, mg/dL | 0.4 (0.3–0.6) | 0.8(0.5–0.9) | 0.125 |
| Direct bilirubin, mg/dL | 0.2 (0.2–0.3) | 0.3 (0.2–0.6) | 0.173 |
| Alkaline phosphatase, U/L | 53 (39–98) | 78 (71–109) | 0.174 |
| Gamma-glutamyl transferase, U/L | 56 (31–88) | 46 (38–144) | 0.715 |
| Albumin, g/L | 31.5 (29.5–35) | 34 (26–39) | 0.571 |
| Lactate dehydrogenase, U/L | 222 (136–308) | 351 (199–490) | 0.317 |
| C-reactive protein, mg/L | 67 (5–129) | 88 (7–95) | 1.000 |
IQR: interquartile range